SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 45 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,443,663 | +1.3% | 3,505,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,400,000 | -19.6% | 3,505,000 | -19.5% | 0.00% | – |
| Q2 2022 | $4,227,000 | -38.9% | 4,355,000 | -38.3% | 0.00% | – |
| Q1 2022 | $6,919,000 | -23.7% | 7,055,000 | -23.4% | 0.00% | – |
| Q4 2021 | $9,072,000 | +0.3% | 9,205,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,043,000 | +16.4% | 9,205,000 | +16.4% | 0.00% | – |
| Q2 2021 | $7,772,000 | +4.6% | 7,905,000 | +2.6% | 0.00% | – |
| Q1 2021 | $7,428,000 | +123.5% | 7,705,000 | +119.8% | 0.00% | – |
| Q4 2020 | $3,324,000 | +183.1% | 3,505,000 | +174.9% | 0.00% | – |
| Q3 2020 | $1,174,000 | +4.6% | 1,275,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,122,000 | +59.6% | 1,275,000 | +45.7% | 0.00% | – |
| Q1 2020 | $703,000 | -18.3% | 875,000 | -7.9% | 0.00% | – |
| Q4 2019 | $860,000 | -2.3% | 950,000 | 0.0% | 0.00% | – |
| Q3 2019 | $880,000 | -5.1% | 950,000 | 0.0% | 0.00% | – |
| Q2 2019 | $927,000 | – | 950,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |